Related Experiment Video
Updated: Aug 23, 2025

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
I have decided about my COVID-19 vaccine, what about my child?
Shlomit Hon Snir1, Sharon Teitler Regev1
1Department of Economic and Management, Yezreel Valley College, Yezreel Valley, Israel.
Insights
Parental willingness to vaccinate children against COVID-19 increases with age, influenced by perceived benefits and trust. A holistic approach is key to understanding these factors for pediatric vaccination acceptance.
Area of Science:
- Public Health
- Epidemiology
- Vaccinology
Background:
- COVID-19 vaccination campaigns have been crucial in controlling the pandemic.
- Vaccine acceptance for pediatric populations remains a concern for some parents.
- Israel's vaccination program initially targeted individuals 16 and older, later extending to 12 and older.
Purpose of the Study:
- To investigate parental acceptance of pediatric COVID-19 vaccination.
- To identify factors influencing vaccination willingness across different child age groups.
- To apply a holistic approach combining various determinants of vaccine acceptance.
Main Methods:
- Online questionnaire distributed in April 2021.
- Survey data collected from 516 parents.
- Analysis incorporating factors from existing vaccine acceptance literature.
Main Results:
- Pediatric COVID-19 vaccine acceptance rates varied by age group: 44.7% (0-6), 53.2% (6-12), and 66.4% (12-16).
- Perceived vaccine benefits positively correlated with parental willingness to vaccinate.
- For ages 12-16, willingness was linked to information access, trust, and community norms; perceiving information as "fake news" also increased willingness.
Conclusions:
- Parental willingness to vaccinate children against COVID-19 is age-dependent.
- A comprehensive, holistic approach is necessary to understand the multifaceted variables influencing parental decisions.
- Addressing parental concerns regarding benefits, information reliability, trust, and community influence is vital for promoting pediatric vaccination.
Abstract:
Vaccination has been instrumental in controlling the COVID-19 pandemic, with numbers of new cases decreasing rapidly even as restrictions to control the spread of the virus were removed. The first stage of the vaccination campaign in Israel covered individuals aged 16 and older, following the U.S. Food and Drug Administration's approval of the vaccine. While the campaign was later extended to those aged 12 and older, some parents continue to have doubts and concerns about the vaccine. Data were collected via an online questionnaire during April 2021; 516 parents participated. This research adopted a holistic approach that combines factors relating to vaccine acceptance previously reported in the literature. The acceptance of pediatric COVID-19 vaccination among parents varied by their children's age groups, at 44.7%, 53.2%, and 66.4% among parents with children aged 0-6, 6-12, and 12-16, respectively. The results of this study indicate that different sets of variables affect the willingness of parents to vaccinate their children, depending on their child's age. Moreover, a holistic approach is necessary in order to correctly verify the significant variables. Parents who evaluate the vaccine as more beneficial have a higher probability of being willing to vaccinate. In addition, for ages 12-16, parental willingness to vaccinate is associated with access to information, trust, and neighborhood norms. Those evaluating information about the vaccine as more fake news show higher probability to vaccinate their children. The timing of the survey is highly relevant, especially considering the uncertainty about the effectiveness and side effects of the vaccine.
More Related Videos
12:09Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
12:53Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022
Related Concept Videos
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics
Teratogenicity